The HCPLive Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.
November 22nd 2024
A study identified homelessness and minority status as factors that impact clozapine prescription patterns.
November 14th 2024
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Predicting Positive and Negative Symptom Exaggeration in Chronic Pain Patients
Sometimes, chronic pain patients intentionally magnify or downplay their physical and mental symptoms during office visits. Despite that fact, little attention in the clinical setting is paid to underlying motives for positively or negatively biased self-reports.
Mindfulness-based Pain Care Provides Opioid Taper Support
Even if a chronic pain patient had been taking opioid medications exactly as prescribed, it would still be possible for the patient to experience negative cognitive and emotional responses to dose tapering that could amplify sensory pain and lead to opioid addiction.
Can a Smoking Cessation Drug Cause Neuropsychiatric Adverse Events?
March 7th 2014When encouraging and supporting patients to quit smoking, varenicline is unlikely to increase the risk of neuropsychiatric adverse events such as suicide, depression, and aggression, even in patients with pre-existing psychiatric illness.
Grouping Fibromyalgia Patients by Symptom Incidence, Severity May Improve Treatment Outcomes
Although fibromyalgia lacks an effective standardized treatment, one part of the problem is the condition's diverse constellation of symptoms that include chronic widespread pain, fatigue, and even depression.
Healthcare Coalition Decries FDA Approval of Extended-Release Zohydro
A 40-member coalition partly comprised of physician experts on opioid addiction treatment and overdose prevention is asking the US Food and Drug Administration to rescind its approval of extended-release Zohydro (hydrocodone bitratrate), given the drug's perceived dangers to the public.
Metabolic Changes Accelerate Cognitive Decline in Type 2 Diabetics
March 3rd 2014Examining evidence from epidemiologic, clinical, and animal studies, a team of researchers discussed the connection between neural dysfunction and metabolic disorders related to type 2 diabetes in the February 2014 issue of Current Diabetes Reports.
Alzheimer's Agitation Eased by Citalopram, But With Severe Adverse Effects
In a recent clinical trial, Celexa (citalopram) reduced agitation in patients with probable Alzheimer's disease (AD) compared to placebo, but the drug also produced severe cognitive and cardiac adverse events that prescribers must consider.
Late-Onset Alzheimer's Disease in Both Parents May Boost Dementia Risk in Adult Offspring
Patients who are free of dementia but have 2 parents with late-onset Alzheimer's disease may show signs of the disease in brain scans several years, if not decades, before they display clinical symptoms.
Heart Disease Linked to Cognitive Decline in Elderly Postmenopaual Women
A recent study published online in the Journal of the American Heart Association discovered an association between cardiovascular disease (CVD) and cognitive decline in postmenopausal women between the ages of 65 and 79 years old.
Dramatic Weight Loss from Bariatric Surgery Can Alter Identity
January 7th 2014While numerous patients require psychiatric interventions before and immediately after surgery, a new report addresses a different psychological process that can occur months or even years later: major quality-of-life (QOL) perception changes related to dramatic weight loss.
What Should I Prescribe for This Man's Depression?
January 1st 2014Several factors should be considered when choosing a medication and dosing schedule for this depressed adult male who reports being "very sensitive" to medication and expresses particular concern about being either sedated or "revved up" from an antidepressant.